HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laurent Monassier Selected Research

imidazoline I1 receptors

11/2019Effects of imidazoline-like drugs on liver and adipose tissues, and their role in preventing obesity and associated cardio-metabolic disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laurent Monassier Research Topics

Disease

10Cardiomegaly (Heart Hypertrophy)
01/2017 - 02/2003
5Body Weight (Weight, Body)
01/2021 - 08/2008
5Hypertrophy
01/2012 - 07/2003
4Hypertension (High Blood Pressure)
01/2018 - 08/2008
4Fibrosis (Cirrhosis)
01/2017 - 07/2011
4Heart Diseases (Heart Disease)
11/2016 - 05/2004
4Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2016 - 05/2004
3Friedreich Ataxia (Friedreich's Ataxia)
12/2020 - 05/2004
3Inflammation (Inflammations)
11/2019 - 01/2016
3Cardiomyopathies (Cardiomyopathy)
05/2014 - 05/2004
3Heart Failure
05/2014 - 06/2007
2Disease Progression
09/2022 - 03/2016
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
12/2021 - 03/2016
2Obesity
01/2021 - 11/2019
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019 - 05/2004
2Pulmonary Hypertension
01/2016 - 12/2010
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
12/2010 - 07/2003
1Angioedema
11/2021
1Overweight
01/2021
1Hypertriglyceridemia
01/2021
1Hypercholesterolemia
01/2021
1Dyslipidemias (Dyslipidemia)
01/2021
1Cardiotoxicity
12/2020
1Mitochondrial Diseases (Mitochondrial Disease)
12/2020
1Hepatocellular Carcinoma (Hepatoma)
11/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2019
1Neuromyelitis Optica (Devic's Disease)
02/2019
1Mitral Valve Prolapse
01/2019
1Heart Valve Diseases (Valvular Heart Disease)
01/2019
1Pathologic Processes
01/2019
1Carcinoid Tumor (Carcinoid)
01/2019
1Carcinoid Heart Disease
01/2019
1Amyotrophic Lateral Sclerosis 8
11/2018
1Insulin Resistance
01/2018
1Atrioventricular Block
01/2017
1Bradycardia
01/2017
1Cysts
11/2016
1Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome)
11/2016
1ST Elevation Myocardial Infarction
04/2016
1Reperfusion Injury
04/2016
1Necrosis
04/2016
1Myocardial Reperfusion Injury
04/2016
1Pulmonary Arterial Hypertension
01/2016
1Ventricular Remodeling
01/2016
1Ventricular Dysfunction
11/2015
1Iron Overload
05/2014

Drug/Important Bio-Agent (IBA)

10Serotonin (5 Hydroxytryptamine)IBA
01/2021 - 07/2003
6Pharmaceutical PreparationsIBA
09/2022 - 12/2004
55-HT2B Serotonin ReceptorIBA
12/2021 - 07/2003
4FrataxinIBA
12/2020 - 05/2004
4Isoproterenol (Isoprenaline)FDA LinkGeneric
07/2011 - 08/2004
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018 - 08/2008
3Atrial Natriuretic Factor (ANF)IBA
01/2016 - 07/2003
3CytokinesIBA
01/2009 - 08/2004
2(3- chloro- 2- methylphenyl)- (4- methyl- 4,5- dihydro- 3H- pyrrol- 2- yl)amineIBA
01/2021 - 11/2019
2ImidazolinesIBA
01/2021 - 11/2019
2AMP-Activated Protein KinasesIBA
11/2019 - 11/2016
2Norepinephrine (Noradrenaline)FDA LinkGeneric
11/2019 - 01/2009
2EnzymesIBA
05/2014 - 05/2004
2Myosin Heavy Chains (Myosin Heavy Chain)IBA
07/2011 - 07/2003
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2008 - 08/2004
2SB 215505IBA
08/2008 - 08/2004
1Quinapril (Accupril)FDA LinkGeneric
11/2021
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2021
1Ramipril (Altace)FDA LinkGeneric
11/2021
1BradykininIBA
11/2021
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
11/2021
1AdiponectinIBA
01/2021
1CholesterolIBA
01/2021
1AcidsIBA
01/2021
1VLDL CholesterolIBA
01/2021
1Natriuretic PeptidesIBA
01/2021
1VLDL LipoproteinsIBA
01/2021
1oxidized low density lipoproteinIBA
01/2021
1Insulin (Novolin)FDA Link
11/2019
1imidazoline I1 receptorsIBA
11/2019
1LigandsIBA
11/2019
1Imidazoline ReceptorsIBA
11/2019
1satralizumabIBA
02/2019
1eculizumabFDA Link
02/2019
1Therapeutic UsesIBA
02/2019
1FilaminsIBA
01/2019
1Extracellular Matrix ProteinsIBA
01/2019
1IgA receptor (protein B)IBA
11/2018
1R-SNARE Proteins (Vesicle-Associated Membrane Protein)IBA
11/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1GlycogenIBA
11/2016
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
04/2016
1Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2016
1SodiumIBA
01/2016
1PotassiumIBA
01/2016
1Messenger RNA (mRNA)IBA
01/2016
1SaltsIBA
01/2016
1ChemokinesIBA
01/2016
1Chemokine ReceptorsIBA
01/2016
1GTP-Binding Proteins (G-Protein)IBA
01/2016
1NF-kappa B (NF-kB)IBA
01/2016
12- amino- 4- (4- fluoronaphth- 1- yl)- 6- isopropylpyrimidineIBA
11/2015

Therapy/Procedure

3Therapeutics
01/2021 - 01/2009
1Drug Therapy (Chemotherapy)
02/2019